Juzen-taiho-to, a Kampo formula, originally consists of a mixture of Shimotsu-to and Shikunshi-to formulas together with two other crude ingredients. Juzen-taiho-to is reported to have a preventive effect on endometrial carcinogenesis in mice. Shimotsu-to exerts an inhibitory effect on estrogen-induced expression of c-fos, interleukin (IL)-1a a and tumor necrosis factor (TNF)-a a in uteri of ovarectomized mice. In the present study, shortand long-term experiments were designed to determine the effects of Juzen-taiho-to and Shimotsu-to on the estrogen-related endometrial carcinogenesis in mouse uteri, associated with the expression of cyclooxygenase (COX)-1 and -2. In the short-term experiment, exposure to Juzen-taiho-to or Shimotsu-to significantly reduced estradiol-17b b (E 2 )-stimulated expressions of COX-2 mRNA (pϽ0.05) as well as the protein. However, no effects on the expression of COX-1 were observed. Shikunshi-to did not affect COX expression. In the long-term experiment, 90 female ICR mice were given N-methyl-N-nitrosourea (MNU) into their uterine corpora. The animals were divided into four groups as follows: group 1, a diet containing 0.07% Shimotsu-to and 5 ppm E 2 ; group 2, a diet containing 5 ppm E 2 ; group 3, a diet containing 0.07% Shimotsu-to; group 4 served as a control. Exposure of Shimotsu-to reduced the incidence of MNU-and E 2 -induced endometrial adenocarcinoma and atypical hyperplasia at the termination of the experiment (30 weeks). The above findings and our previous reports suggest that Shimotsu-to is responsible for the preventive effects of Juzen-taiho-to on estrogen-related endometrial carcinogenesis in mice, through the inhibition of estrogen-related COX-2 as well as c-fos, IL-1a a and TNF-a a expressions.
Juzen-taiho-to is a tonic formula in Kampo Medicine, mainly consisting of Shimotsu-to and Shikunshi-to (Table 1) . Juzen-taiho-to is reported to reduce metastatic potential 1) and to enhance cytokine induction, 2) production of antibody 3) or anti-tumor activity. [4] [5] [6] Shimotsu-to is composed of four crude herbs (Rehmanniae radix, Paeoniae radix, Cnidii rhizoma and Angelicae radix in Table 1 ), possessing the ability to improve deficiencies of 'Ketsu' (a concept referring to blood), hormones, the autonomic nervous system and other regulatory functions of the body's internal environment. 7) In Japan, Shimotsu-to is indicated to be used for poor blood circulation and irregular menstration, etc. Meanwhile, Shikunshi-to is also composed of four crude herbs (Ginseng radix, Atractyloidis rhizoma, Holen and Glycyrrhizae radix in Table 1 ), and used for improving a depression of 'Ki' (a concept that encompasses mental nervous function), especially the appetite for food and the actual process of digesting and absorbing nutrients. 7) In Japan, Shikunshi-to is indicated to be used for gastro-intestinal weakness and chronic gastritis, etc.
The transient expression of the immediate early gene, cfos/jun, is considered to be necessary for cellular proliferation and differentiation. [8] [9] [10] [11] c-Fos/jun mRNA in the uterine corpora of the ovarectomized mice is overexpressed by estrogens. [12] [13] [14] In addition, internal cytokines, such as interleukin (IL)-1a or tumor necrosis factor (TNF)-a contribute to tumor promotion or progression in chemical carcinogenesis. [15] [16] [17] [18] Previously, we reported that Juzen-taiho-to has an inhibitory effect on estradiol-17b (E 2 )-related endometrial carcinogenesis in mice. 19) More recently, we have also reported that Shimotsu-to is the main part of Juzen-taiho-to for the inhibitory effects in E 2 -induced expression of c-fos, IL-1a and TNF-a mRNA and their proteins in the uterine corpora of the ovarectomized mice. 20) Meanwhile, it is known that cyclooxygenase (COX), an enzyme activating production of prostaglandins from arachidonic acid, has two isoforms (1 and 2). The function of inducible COX-2 is associated with carcinogenesis in the large bowel, prostatic gland, stomach, breast and other organs. [21] [22] [23] [24] In addition, the expression of COX-2 is noted to increase in human endometrial carcinoma. 25, 26) These circumstances prompted us to determine if Shimotsu-to exerts inhibitory effects on mouse endometrial carcinogensis induced by MNU and E 2 . Furthermore, the effects of Juzen-taiho-to and Shimotsu-to on the expression of COX-1 and -2 mRNAs and their proteins were investigated.
MATERIALS AND METHODS

Animals and Chemicals
Female ICR mice, 10 weeks of age, were purchased from Japan SLC Co. (Shizuoka). The base diet (Oriental MF, Oriental Yeast Co., Tokyo) and filtered tap water were available ad libitum throughout the experiment. E 2 and MNU were purchased from Sigma Chem Co. (St. Louis, MO, U.S.A.). Juzen-taiho-to, Shimotsu-to and Shikunshi-to were purchased from Tsumura Co. (Tokyo). The ingredients of Juzen-taiho-to, Shimotsu-to and Shikushito are shown in Table 1 . Juzen-taiho-to was prepared as follows. 7) A mixture of Angelicae radix (3.0 g), Cnidii rhizoma (3.0 g), Paeoniae radix (3.0 g), Rehmanniae radix (3.0 g), Ginseng radix (3.0 g), Atractylodis radix (3.0 g), Holen (3.0 g), Glycyrrhizae radix (1.5 g), Astragali radix (3.0 g), and Cinnamomi cortex (3.0 g) was added to 285 ml of water and a solution extracted at 100°C for 1 h. The extracted solution was filtered, and the filtrate was spray-dried to obtain the dry extract powder (5.0 g). Shimotsu-to and Shikunshi-to were prepared in the same way as Juzen-taiho-to, and 2.5 g dry powder was obtained from crude ingredients, respectively (Table 1) .
Experimental Protocol for Short-Term Effects of Kampo Formula Female ICR mice, 12 weeks-of-age, were ovarectomized under general anesthesia with diethylether. Two weeks later, the ovarectomized mice were divided into five groups. Group 1 was given a diet containing 0.2% Juzentaiho-to and 5 ppm E 2 (nϭ5). The dose of Juzen-taiho-to in the diet (0.2%) was equivalent to the clinical dose (7.5 g/ 50 kg daily); group 2 was given 0.07% Shimotsu-to and 5 ppm E 2 (nϭ5), and 0.07% Shimotsu-to was equal to the weight ratio of Juzen-taiho-to; group 3 was fed on a diet containing 0.08% Shikunshi-to and 5 ppm E 2 (nϭ5), and 0.08% Shikunshi-to was equal to the weight ratio of Juzen-taiho-to; group 4 was fed on a diet containing 5 ppm E 2 alone (nϭ6); group 5 served as a non-treatment control (nϭ4). After two weeks on the above diet, the mouse uteri were resected and cut in half longitudinally. One half was quickly frozen in liquid nitrogen for the following experiments, and the other was subjected to pathological examinations.
Reverse Transcriptase-PCR (RT-PCR) Total RNA was isolated from frozen tissues by a guanidium thiocyanate-phenol-chloroform extraction method. 27) Total RNA (3 mg) was reverse transcribed with Moloney murine leukemia virus reverse transcriptase (MMLV-RTase, 200 units, Gibco BRL, Gaitherburg, MO, U.S.A.) in 20 mM Tris-HCl buffer (PH 8.4) with 50 mM KCl, 2.5 mM MgCl 2 , 0.1 mg/ml bovine serum albumin, 10 mM dithiothreitol, and 0.5 mM deoxynucleotides to generate cDNAs, using random hexamers (50 ng, Gibco BRL) at 37°C for 60 min. RT reaction was carried out at 94°C for 5 min to inactivate MMLV-RTase. For COX-2 (583 bp), treatment included 35 cycles of PCR consisting of 15 s at 94°C for denaturation, 1 min at 55°C for annealing, and 1 min at 72°C for extension. For COX-1, treatment included 35 cycles of 1 min at 94°C for denaturation, 1 min at 57°C for annealing, and 1 min at 72°C for extension. These processes were carried out in reverse transcribed cDNAs with the 0.1 mM specific primers described below, using an IWAKI thermal sequencer TSR-300 (IWAKI Glass, Tokyo) with Vent DNA polymerase (New England Biolabs, Bervely, MA, U.S.A.) in 20 mM Tris-HCl buffer (PH 8.8) with 10 mM KCl, 10 mM (NH 4 ) 2 SO 4 , 2 mM MgSO 4 , 0.1% Triton X-100, and 0.15 mM dexynucleotide phosphates. Twenty cycles of PCR for glyceraldehyde-3-phosphate dehydrogenase (GAPDH, a house-keeping gene) mRNA (252 bp) as an internal standard were performed at the same time.
The following oligodeoxynucleotides were synthesized as specific primers in PCR according to the published information [cDNA for COX-1, 2 28) and GAPDH 29) ] as shown in Table 2 .
Semi-quantitative Analysis of COX-1 and COX-2 mRNA Expression in the Mice Uterine Corpus by PCR Products PCR products were applied on 1.5% agarose gel electrophoresis at 50-100 V. The quantification of the products was carried out with Bio image (Nihon Millipore Corp., Tokyo). The intensity of specific bands was standardized with that of GAPDH mRNA.
Experimental Protocol for Long-Term Effects of Kampo Formulas A total of 90 female ICR mice, 10 weeks of age, underwent laparotomy under general anesthesia with diethylether. MNU solution (total volume: 0.1 ml) at a dose of 1 mg/100 g body weight was injected into the left uterine tube and normal saline into the right. One week after the exposure to MNU, the animals were divided into the following four experimental groups. Group 1 (20 mice) was given a diet containing 0.07% Shimotsu-to and 5 ppm E 2 . Group 2 (30 mice) was treated with 5 ppm E 2 alone. Group 3 (10 mice) were fed with a diet containing 0.07% Shimotsuto. The doses of E 2 and Kampo formulas were the same as in the short-term assay, and the above diets were given throughout the experiment. Group 4 (30 mice) served as a control group. Thirty weeks after the start of the experiment, all major organs, especially the reproductive organs, were grossly inspected. The uterus, ovaries, vagina, and other lesions suspected of being hyperplastic or neoplastic were cut in half. One half was quickly frozen in liquid nitrogen for the following experiments, and the other was subjected to pathological examinations. The weight of each uterine corpus was determined. After being fixed in 10% formaline, tissues were sectioned at 3 mm and stained with hematoxyline and eosin.
Immunohistochemical Expression of COX-1 and COX-2 Proteins After being fixed in 10% formalin, half the uterine corpus was processed for the conventional staining. Briefly, the avidin-biotin-peroxidase complex was applied to the sections using a Vestain kit (Vector, Burlingame, CA, U.S.A.). The primary antibodies used were against the proteins of COX-1 (1 : 250, anti-mouse monoclonal, Cayman Chemial, Ann Arbor, MI, U.S.A.) and COX-2 (1 : 200, antimouse monoclonal, Alexis Biochem., Carlsbad, CA, U.S.A.).
Immunohistochemical COX-1 and -2 expressions in glandular and stromal cells were basically scored separately according to the criteria of Krajewska et al. 30) The scoring methods were modified by Fujiwaki et al. 31) Namely, the percentage of COX-1 and -2 immunostaining in the glandular and stromal cells were graded as follows: 0, no staining; 1, 1-25%; 2, 51-75%; 3, 50-75%; and 4, 76-100%. Intensity of immunostaining was rated as follows: 0, none; 1, weak; 2, moderate; 3, intense. Thus, the immunohistochemical COX scores were ranged from 0 to 12.
31)
Histology of the Uterine Lesions Uterine endometrial lesions were divided into 4 lesions according to the WHO criteria.
32) a) endometrial hyperplasia, simple; b) endometrial hyperplasia, complex; c) atypical endometrial hyperplasia; d) adenocarcinoma.
Semi-quantitative Analysis of COX-1 and COX-2 mRNA Expression of the Hyperplastic and Neoplastic Endometrial Lesions
The frozen tissues of group 2 (treated with MNU and E 2 ) in the long-experiment were served for evaluations for COX-1, -2 mRNA expressions. The examination methods were same as the short-term experiments. Adenocarcinoma (nϭ5), atypical hyperplasia (nϭ4), endometrial hyperplasia, complex (nϭ5), simple (nϭ5) and the hitopatholocally normal uterine corpus were examined.
Statistical Analysis Statistical analysis was done according to the c 2 test or Student's t test.
RESULTS
Short-Term Experiment
The levels of COX-1 and -2 mRNA expression are shown in Fig. 1 . Juzen-taiho-to or Shimotsu-to treatment significantly reduced the E 2 -induced expression of COX-2 (pϽ0.05) alone, whereas no change was found for COX-1 in each group. Shikunshi-to did not affect COX expression.
Representative immunohistochemical expression of COX-2 in the uteri treated with E 2 with or without Shimotsu-to is shown in Fig. 2 . Shimotsu-to treatment reduced the COX-2 expression induced by E 2 . The immunohistochemical score COX-1 and -2 is summarized in Table 3 . Juzen-taiho-to treatment significantly reduced the COX-2 immunohistochemical scores of the glandular (pϽ0.01) and stromal cells (pϽ0.05) induced by E 2 treatment. Shimotsu-to treatment also significantly reduced the COX-2 immunohistochemical scores of the glandular cells compared with E 2 -treated group (pϽ 0.01), whereas it showed a decreased tendency in the stromal cells. Shikunshi-to appeared to have no effect on COX-expression.
Long-Term Experiment One mouse in group 1, four in group 2, three in group 3, and four in group 4 died within 15 weeks, yet no pathological abnormalities other than pneumonia were found. The remaining animals survived until the termination of the experiment and were enrolled as effective animals (Table 4) . No significant difference in mean body weights was found between the corresponding groups with or without E 2 -treatment. Under E 2 -treatment, the mean wet 158 Vol. 27, No. 2 The expression was most prominent in the glandular cells treated with E 2 alone. The COX-2 expression by adding of Shimotsu-to was decreased compared with E 2 alone (sABC stain, ϫ200).
Fig. 1. Expressions of COX-1, -2 mRNA Treated with E 2 Plus Juzentaiho-to (J-t-t), Shimotsu-to (S-m-t), or Shikunshi-to (S-k-t) J-t-t and S-m-t treatment significantly reduced the expressions of COX-2 induced by E 2 (pϽ0.05). Effects of three
weight of left and right uterine corpora of group 1 was significantly less than that of group 2 (pϽ0.01).
Histological properties of endometrial hyperplasias and adenocarcinoma in the present study were as the same as in our previous report. 8, 12, 14) All adenocarcinomas seen in the endometria were well-or moderately-differentiated. The incidence of the preneoplastic and neoplastic lesions of the endometria is summarized in Table 5 . The incidence of adenocarcinoma, atypical hyperplasia and endometrial hyperplasia, complex on the treated side of the uterine corpus of group 1 (treated with Shimotsu-to) was significantly lower than that of group 2 (treated with E 2 alone). The incidence of adenocarcinoma and atypical hyperplasia on the right side of group 1 showed a decreased tendency compared with that of group 2.
The levels of COX-1, -2 mRNA expression of the neoplastic and pre-neoplastic endometrial lesions are shown in Fig.  3 . The COX-2 mRNA expression of adenocarcinoma was significantly higher than the normal control (pϽ0.05). The level of COX-2 mRNA showed an increased tendency according to the hyperplastic changes (Atypical hyperplasiaϾ endometrial hyperplasia, complexϾendometrial hyperplasia, simple), although significant differences could not be found. Meanwhile, the COX-1 mRNA expression was almost same in each group.
DISCUSSION
In our previous experiment, Juzen-taiho-to showed a suppressive effect on E 2 -related endometrial carcinogenesis in mice, possibly through suppression of estrogen-induced cfos/jun expression. 8) More recent report noted that Juzentaiho-to and Shimotsu-to suppress the estrogen-mediated expression of c-fos, IL-1a, and TNF-a in the mouse uterine corpora treated with E 2 . 20) There is more evidence showing that TNF-a and IL-1a play a significant role in chemical carcinogenesis. 15, 17, 33) TNF-a is thus considered to stimulate not only tumor promotion but also progression in carcinogenesis. 18) Since COX-2 expression is known to be associated with estrous cycle in the uteri, 34) ovarectomized mice were used for the evaluation of COX-2 expression in the present study. Although the enzyme activity was not evaluated in the present study, COX-2 mRNA and protein expressions in the uteri of mice treated with Juzen-taiho-to or Shimotsu-to were lower than in the uteri of mice treated with E 2 alone.
The expression of COX-2 is noted to increase in the human endometrial carcinoma. 25, 26, 31) From the present study and previous our study in the long-term assay, 35) the COX-2 expressions showed as follows; adenocarcinomaϾendome-trial hypeplasiasϾthe histologically normal endometria in the mouse uteri, suggesting that the COX-2 overexpression is related to E 2 -induced endometrial carcinogenesis in mice. From the increased expression of COX-2 in the human and mice endometria, suppression of COX-2 is suggested to be an effective strategy for prevention of endometrial carcinogenesis. In this study, Shimotsu-to similarly reduced COX-2 expression and the incidence of the preneoplastic and neoplastic lesions in the mouse uteri,as did Juzen-taiho-to. Thus, Shimotsu-to in Juzen-taiho-to is suggested to be the agent responsible for the prevention of endometrial carcinogenesis in mice.
Juzen-taiho-to reduced the E 2 -induced expression of COX-2 to a greater extent than Shimotsu-to (Fig. 1) . Juzen-taiho-to contained two other ingredients, Astragali radix and Cinnamomi cortex other than four of Shimotsu-to (Table 1) . Recently, Astragali radix is reported to have anti-inflammatory effects through suppression of IL-6 and prostaglandin productions. 36) Cinnamon cortex exerts anti-inflammatory effects. 37) These anti-inflammatory effects might be associated with COX-expressions. This might be the reason why Juzentaiho-to had a more decreased effect on COX-2 expression than Shimotsu-to.
Meanwhile, it is known that Juzen-taiho-to has antimetastatic effects in different animal models. 1, 6) The major mechanism for the effects are speculated to be the activation of macrophages and/or T cells in the host immune system. 1) Juzen-taiho-to as well as Shimotsu-to is reported to inhibit the production of cytokines, such as IL-1a and TNF-a. 20) Such inhibitory effects may be related to the suppression of endometrial carcinogenesis in mice.
In summary, Shimotsu-to exerted inhibitory effects on the expression of COX-2 as well as c-fos, IL-1a or TNF-a in the endometrium on MNU-and E 2 -induced endometrial carcinogenesis in mice, suggesting that Shimotsu-to in Juzen-taihoto is a key formula for the prevention of the endometrial carcinogensis. 
